{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:31:30Z","timestamp":1790721090246,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.cll.2009.06.005","type":"journal-article","created":{"date-parts":[[2009,8,11]],"date-time":"2009-08-11T07:06:52Z","timestamp":1249974412000},"page":"193-228","source":"Crossref","is-referenced-by-count":10,"title":["Laboratory Testing for\u00a0von Willebrand Disease: Toward a Mechanism-Based Classification"],"prefix":"10.1016","volume":"29","author":[{"given":"Richard","family":"Torres","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Fedoriw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0046-8177(87)80332-5","article-title":"von Willebrand disease","volume":"18","author":"Zimmerman","year":"1987","journal-title":"Hum Pathol"},{"issue":"19","key":"10.1016\/j.cll.2009.06.005_bib2","doi-asserted-by":"crossref","first-page":"7899","DOI":"10.1073\/pnas.0608422104","article-title":"Shear-induced unfolding triggers adhesion of von Willebrand factor fibers","volume":"104","author":"Schneider","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib3","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1055\/s-2003-44556","article-title":"Shear stress and von Willebrand factor in health and disease","volume":"29","author":"Tsai","year":"2003","journal-title":"Semin Thromb Hemost"},{"issue":"Suppl 4","key":"10.1016\/j.cll.2009.06.005_bib4","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0049-3848(08)70028-8","article-title":"VWF attributes\u2014impact on thrombus formation","volume":"122","author":"Reininger","year":"2008","journal-title":"Thromb Res"},{"key":"10.1016\/j.cll.2009.06.005_bib5","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1111\/j.1538-7836.2005.01429.x","article-title":"GPVI and integrin alphaIIb\/beta3 signaling in platelets","volume":"3","author":"Watson","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cll.2009.06.005_bib6","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1182\/blood-2004-04-1257","article-title":"Integrins: dynamic scaffolds for adhesion and signaling in platelets","volume":"104","author":"Shattil","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cll.2009.06.005_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib8","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/beha.2001.0132","article-title":"Biosynthesis, processing and secretion of von Willebrand factor: biological implications","volume":"14","author":"de Wit","year":"2001","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.devcel.2005.12.012","article-title":"The physiological function of von Willebrand's factor depends on its tubular storage in endothelial Weibel-Palade bodies","volume":"10","author":"Michaux","year":"2006","journal-title":"Dev Cell"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib10","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/beha.2001.0133","article-title":"Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation","volume":"14","author":"Ruggeri","year":"2001","journal-title":"Baillieres Best Pract Res Clin Haematol"},{"issue":"50","key":"10.1016\/j.cll.2009.06.005_bib11","doi-asserted-by":"crossref","first-page":"38266","DOI":"10.1074\/jbc.M607123200","article-title":"Solution structure of human von Willebrand factor studied using small angle neutron scattering","volume":"281","author":"Singh","year":"2006","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"10.1016\/j.cll.2009.06.005_bib12","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1242\/jcs.03494","article-title":"Formation and function of Weibel-Palade bodies","volume":"121","author":"Metcalf","year":"2008","journal-title":"J Cell Sci"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pbc.20658","article-title":"Regulated release of VWF and FVIII and the biologic implications","volume":"46","author":"Haberichter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cll.2009.06.005_bib14","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1182\/blood.V88.8.2951.bloodjournal8882951","article-title":"Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of l-Deamino-8-DArginine vasopressin in humans","volume":"88","author":"Borchiellini","year":"1996","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib15","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1182\/blood-2007-12-130740","article-title":"Basal secretion of von Willebrand factor from human endothelial cells","volume":"112","author":"Giblin","year":"2008","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1160\/TH05-07-0527","article-title":"Plasma von Willebrand factor, thrombosis, and the endothelium: the first 30 years","volume":"95","author":"Blann","year":"2006","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cll.2009.06.005_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0022-2143(97)90019-6","article-title":"von Willebrand disease and quantitative variation in von Willebrand factor","volume":"130","author":"Mohlke","year":"1997","journal-title":"J Lab Clin Med"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1160\/TH07-10-0629","article-title":"Clearance of von Willebrand factor","volume":"99","author":"Denis","year":"2008","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib20","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"von Willebrand factor and von Willebrand disease","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis","volume":"71","author":"Sadler","year":"1994","journal-title":"Thromb Haemost"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib22","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/107602960601200217","article-title":"von Willebrand factor antigen latex immunoassays are affected to a different extent by rheumatoid factor","volume":"12","author":"Schlammadinger","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"10.1016\/j.cll.2009.06.005_bib24","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1538-7836.2004.00838.x","article-title":"Standardization of factor VIII and von Willebrand factor in plasma: calibration of the WHO 5th International Standard (02\/150)","volume":"2","author":"Hubbard","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib25","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1309\/CEPND3LFHQ87XU4D","article-title":"A new automated screening assay for the diagnosis of von Willebrand disease","volume":"127","author":"Salem","year":"2007","journal-title":"Am J Clin Pathol"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.mbc.0000233365.10981.08","article-title":"Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease","volume":"17","author":"De Vleeschauwer","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.3324\/haematol.10766","article-title":"Evaluation of a new turbidimetric assay for von Willebrand factor activity useful in the general screening of von Willebrand disease","volume":"92","author":"Pinol","year":"2007","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib28","first-page":"77","article-title":"A sensitive ristocetin co-factor activity assay with recombinant glycoprotein Ibalpha for the diagnosis of patients with low von Willebrand factor levels","volume":"89","author":"Federici","year":"2004","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib29","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib30","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/elps.200390068","article-title":"Rapid high-resolution electrophoresis of multimeric von Willebrand Factor using a thermopiloted gel apparatus","volume":"24","author":"Smejkal","year":"2003","journal-title":"Electrophoresis"},{"issue":"8","key":"10.1016\/j.cll.2009.06.005_bib31","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.cll.2009.06.005_bib32","first-page":"371","article-title":"A better approach to monitoring of therapy in von Willebrand disease?","volume":"100","author":"Favaloro","year":"2008","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib33","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2006.01771.x","article-title":"Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function","volume":"4","author":"Hayward","year":"2006","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.cll.2009.06.005_bib34","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1055\/s-0029-1145254","article-title":"Clinical utility of the PFA-100","volume":"34","author":"Favaloro","year":"2008","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.cll.2009.06.005_bib35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1160\/TH07-08-0527","article-title":"PFA-100 monitoring of von Willebrand factor (VWF) responses to desmopressin (DDAVP) and factor VIII\/VWF concentrate substitution in von Willebrand disease type 1 and 2","volume":"100","author":"van Vliet","year":"2008","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib36","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2007.06850.x","article-title":"Differential identification of a rare form of platelet-type (pseudo-) von Willebrand disease (VWD) from Type 2B VWD using a simplified ristocetin-induced-platelet-agglutination mixing assay and confirmed by genetic analysis","volume":"139","author":"Favaloro","year":"2007","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib37","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1172\/JCI111112","article-title":"von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease","volume":"72","author":"Miller","year":"1983","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2141.2008.07311.x","article-title":"Von Willebrand factor propeptide makes it easy to identify the shorter Von Willebrand factor survival in patients with type 1 and type Vicenza von Willebrand disease","volume":"143","author":"Sztukowska","year":"2008","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib39","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib40","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1538-7836.2008.02845.x","article-title":"A highly-sensitive plasma von Willebrand factor ristocetin cofactor (VWF: RCo) activity assay by flow cytometry","volume":"6","author":"Chen","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"12","key":"10.1016\/j.cll.2009.06.005_bib42","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3324\/haematol.11313","article-title":"Laboratory diagnosis and monitoring of desmopressin treatment of von Willebrand's disease by flow cytometry","volume":"92","author":"Giannini","year":"2007","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.cll.2009.06.005_bib43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ajcp\/111.3.418","article-title":"Binding of von Willebrand factor to collagen by flow cytometry","volume":"111","author":"Kempfer","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.cll.2009.06.005_bib44","unstructured":"Torres R, Levene M. Clinical multimer analysis of vWF by fluctuation spectroscopy, In: SPIE Photonics West; 24\u201329 January 2009; San Jose, CA, Photonics West 2009-BiOS: Biomedical Optics (Special Collection) Proceedings of SPIE Volume: CDS329, SPIE, Bellingham, WA, 2009. Abstract# 7186\u201315."},{"issue":"6","key":"10.1016\/j.cll.2009.06.005_bib45","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.cll.2009.06.005_bib46","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/01.ATV.20.8.2024","article-title":"Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time","volume":"20","author":"Souto","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib47","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2141.2004.05249.x","article-title":"Relationship between ABO and Secretor genotype with plasma levels of factor VIII and von Willebrand factor in thrombosis patients and control individuals","volume":"128","author":"Schleef","year":"2005","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.cll.2009.06.005_bib48","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1182\/blood-2006-07-035105","article-title":"Effect of von Willebrand factor Y\/C1584 on in vivo protein level and function and interaction with ABO blood group","volume":"109","author":"Davies","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib49","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1046\/j.1538-7836.2003.00367.x","article-title":"Measurement of von Willebrand factor activity: relative effects of ABO blood type and race","volume":"1","author":"Miller","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"7","key":"10.1016\/j.cll.2009.06.005_bib50","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-11-122945","article-title":"A shorter von Willebrand factor survival in O blood group subjects explains how ABO determinants influence plasma von Willebrand factor","volume":"111","author":"Gallinaro","year":"2008","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib51","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1111\/j.1537-2995.2006.00975.x","article-title":"ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?","volume":"46","author":"Jenkins","year":"2006","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib52","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1373\/clinchem.2006.070730","article-title":"Performance and clinical utility of a commercial von Willebrand factor collagen binding assay for laboratory diagnosis of von Willebrand disease","volume":"52","author":"Popov","year":"2006","journal-title":"Clin Chem"},{"issue":"6","key":"10.1016\/j.cll.2009.06.005_bib53","first-page":"688","article-title":"Fainting induces an acute increase in the concentration of plasma factor VIII and von Willebrand factor","volume":"88","author":"Casonato","year":"2003","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib54","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM-1 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.cll.2009.06.005_bib55","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1111\/j.1538-7836.2008.03182.x","article-title":"Generation and validation of the Condensed MCMDM-1VWD Bleeding Questionnaire for von Willebrand disease","volume":"6","author":"Bowman","year":"2008","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib56","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.bcmd.2008.03.004","article-title":"Genetic defects in von Willebrand disease type 3 in Indian and Greek patients","volume":"41","author":"Gupta","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.cll.2009.06.005_bib57","doi-asserted-by":"crossref","unstructured":"Tamura A, Iwata M, Fukunishi S, et\u00a0al. Identification of newly polymorphic intron 40 markers of the von Willebrand factor gene in a Japanese population. Legal Medicine, in press. doi:10.1016\/j.legalmed.2008.11.004.","DOI":"10.1016\/j.legalmed.2008.11.004"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib58","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib59","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105.","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib60","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1111\/j.1538-7836.2008.02945.x","article-title":"Detailed von Willebrand factor multimer analysis in patients with von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 von Willebrand disease (MCMDM-1VWD)","volume":"6","author":"Budde","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1538-7836.2003.00435.x","article-title":"Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues","volume":"2","author":"Tjernberg","year":"2004","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029606293422","article-title":"Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease","volume":"12","author":"Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.cll.2009.06.005_bib63","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1111\/j.1365-2516.2008.01966.x","article-title":"Contribution of genetical analysis for diagnosis of von Willebrand's disease type 2B","volume":"15","author":"Victor","year":"2009","journal-title":"Haemophilia"},{"key":"10.1016\/j.cll.2009.06.005_bib64","doi-asserted-by":"crossref","unstructured":"Federici A, Mannucci PM, Castaman G, et\u00a0al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood (online prepublication Sep 19, 2008). doi:10.1182\/blood-2008-04-152280.","DOI":"10.1182\/blood-2008-04-152280"},{"issue":"8","key":"10.1016\/j.cll.2009.06.005_bib65","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2006-03-009449","article-title":"Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia","volume":"108","author":"Nurden","year":"2006","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.cll.2009.06.005_bib66","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1160\/TH06-11-0647","article-title":"Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain","volume":"97","author":"Casonato","year":"2007","journal-title":"Thromb Haemost"},{"issue":"3","key":"10.1016\/j.cll.2009.06.005_bib67","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/S1079-9796(03)00033-0","article-title":"Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients","volume":"30","author":"Baronciani","year":"2003","journal-title":"Blood Cells Mol Dis"},{"issue":"10","key":"10.1016\/j.cll.2009.06.005_bib68","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1182\/blood-2008-08-173021","article-title":"Correction of murine ADAMTS13 deficiency by hematopoietic progenitor cell-mediated gene therapy","volume":"113","author":"Laje","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib69","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1751-553X.2007.00978.x","article-title":"Clinical, laboratory and therapeutic aspects of platelet-type von Willebrand disease","volume":"30","author":"Franchini","year":"2008","journal-title":"Int J Lab Hematol"},{"issue":"5","key":"10.1016\/j.cll.2009.06.005_bib70","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ajh.20830","article-title":"Acquired von Willebrand syndrome: an update","volume":"82","author":"Franchini","year":"2007","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.cll.2009.06.005_bib71","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0049-3848(02)00053-1","article-title":"Deficiency of von Willebrand factor-cleaving protease activity in the plasma of malignant patients","volume":"105","author":"Koo","year":"2002","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib72","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood.V94.2.610","volume":"94","author":"Galbusera","year":"1999","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.cll.2009.06.005_bib73","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1177\/1076029606291385","article-title":"Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay","volume":"12","author":"Casonato","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"10.1016\/j.cll.2009.06.005_bib74","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1053\/j.seminhematol.2004.09.009","article-title":"von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis","volume":"42","author":"Martinelli","year":"2005","journal-title":"Semin Hematol"},{"issue":"7","key":"10.1016\/j.cll.2009.06.005_bib75","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00277-006-0085-5","article-title":"Von Willebrand factor and thrombosis","volume":"85","author":"Franchini","year":"2006","journal-title":"Ann Hematol"},{"issue":"11","key":"10.1016\/j.cll.2009.06.005_bib76","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1161\/01.STR.0000244767.39962.f7","article-title":"High von Willebrand factor levels increase the risk of first ischemic stroke: influence of ADAMTS13, inflammation, and genetic variability","volume":"37","author":"Bongers","year":"2006","journal-title":"Stroke"},{"issue":"7","key":"10.1016\/j.cll.2009.06.005_bib77","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1161\/01.CIR.100.7.736","article-title":"Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators","volume":"100","author":"Folsom","year":"1999","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.cll.2009.06.005_bib78","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0002-9343(02)01345-1","article-title":"Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE)","volume":"113","author":"Tsai","year":"2002","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.cll.2009.06.005_bib79","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271209000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271209000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T09:38:24Z","timestamp":1590053904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271209000456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":79,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0272271209000456"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2009.06.005","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}